stockportfolio.pro
AptarGroup, Inc. (ATR)
Healthcare · Medical Instruments & Supplies · NYSE
AptarGroup, Inc. revenue & earnings — last 10 fiscal years
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.33B | $2.47B | $2.76B | $2.86B | $2.93B | $3.23B | $3.32B | $3.49B | $3.58B | $3.78B |
| Gross profit | $687.38M | $723.46M | $795.51M | $874.39M | $906.01M | — | — | — | — | — |
| Net income | $205.60M | $220.03M | $194.77M | $242.23M | $214.04M | $244.10M | $239.29M | $284.49M | $374.54M | $392.79M |
| Net margin | 8.8% | 8.9% | 7.0% | 8.5% | 7.3% | 7.6% | 7.2% | 8.2% | 10.5% | 10.4% |
Source: AptarGroup, Inc. SEC filings (10-K). 18 years of history available in the interactive view.
What growth is priced into ATR stock?
At today's market cap of $7.30B, AptarGroup, Inc. is priced for free-cash-flow growth of about 10.4% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $299.58M from the FY ending 2025-12-31). For comparison, free cash flow actually grew -1.6%/yr over the last five fiscal years and revenue 5.2%/yr, computed from its SEC filings. This is a reverse DCF — a translation of the price into a growth assumption you can judge, not a fair value and not advice. Change the assumptions yourself in the interactive view →
Explore 18 years of AptarGroup, Inc. financials — interactive
Full income statement, balance sheet and cash flow with CAGR and trend on every row, 48 quarters, valuation ratios, plain-English health checks, and Ask — our SEC-grounded research assistant.
Open the interactive view — freeOr start a 7-day free trial to track ATR in your portfolio →
AptarGroup, Inc. financial history by metric
About AptarGroup, Inc.
AptarGroup, Inc. designs and manufactures drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, fragrance, facial skincare, color cosmetics, personal care, home care, and food and beverage markets. The company operates through three segments: Pharma, Beauty, and Closures. It provides dispensing pumps used to dispense sprays, liquids, or lotions from non-pressurized containers; fine-mist pumps for pharmaceutical and fragrance applications; and lotion pumps for viscous formulations, as well as closures, such as dispensing and non-dispensing solutions that enable product delivery without removal of the cap and used across various consumer end markets. The company also offers aerosol valves used in pressurized containers and continuous spray and metered-dose valves for pharmaceutical, personal care, and household applications; elastomeric primary packaging components; active material science solutions; and digital health solutions. The company primarily sells its products and services in Asia, Europe, Latin America, and North America. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.
AptarGroup, Inc. — frequently asked questions
What is AptarGroup, Inc.'s revenue?
AptarGroup, Inc. (ATR) reported revenue of $3.78B for fiscal year 2025, up 5.4% from the prior year, according to its SEC filings.
Is AptarGroup, Inc. profitable?
Yes. ATR earned net income of $392.79M in fiscal 2025, a net margin of 10.4%.
What is ATR's P/E ratio?
AptarGroup, Inc. trades at a price-to-earnings ratio of about 19.6 based on the latest data in our nightly-refreshed cache.
How fast is AptarGroup, Inc. growing?
ATR's revenue grew at roughly 5.2% per year over the last five fiscal years (compound annual growth rate), computed from SEC-filed statements.
How much debt does AptarGroup, Inc. have?
As of fiscal year 2025, ATR carried roughly $183.95M in total debt (short- plus long-term borrowings), per its filed balance sheet.
What is AptarGroup, Inc.'s market cap?
AptarGroup, Inc. (ATR) has a market capitalization of about $7.30B, based on the latest data in our nightly-refreshed cache.
When does AptarGroup, Inc.'s fiscal year end?
ATR's fiscal year ends in December. Its most recent annual filing covers the fiscal year ending 2025-12-31.
What growth is priced into ATR stock?
At today's market cap of $7.30B, AptarGroup, Inc. is priced for free-cash-flow growth of about 10.4% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $299.58M from the FY ending 2025-12-31). For comparison, free cash flow actually grew -1.6%/yr over the last five fiscal years and revenue 5.2%/yr, computed from its SEC filings.
Where does this data come from?
All figures are computed from AptarGroup, Inc.'s official SEC filings (10-K and 10-Q), covering 18 years of history, refreshed nightly. stockportfolio.pro does not provide investment advice.